Summary: A criminal trial in Madrid over alleged animal mistreatment at the Vivotecnia testing laboratory has revived a wider European question: how quickly can the EU move from promises on animal welfare to enforceable change? The case, based on undercover footage first made public in 2021, concerns two technicians who deny wrongdoing. But for animal-protection groups, the hearings have become a test of whether Europe’s rules on laboratory animals are strong enough, transparent enough and ambitious enough to match public expectations.
A Madrid courtroom has placed one of Europe’s most sensitive scientific and ethical debates back under public scrutiny: the use of live animals in laboratories. The immediate case is narrow. Two workers at Vivotecnia, a contract research laboratory based in Tres Cantos, near Madrid, have faced criminal proceedings over alleged mistreatment and serious injury to animals. Both deny the accusations.
Yet the political meaning of the case is much broader. Cruelty Free Europe, one of the organisations involved in the case, has described the hearings as a moment in which the “entire animal testing industry” is effectively under examination. That is an advocacy position, but it captures the depth of the unease now surrounding Europe’s system of authorising, supervising and reducing animal experiments.
A case born from undercover footage
The case stems from footage recorded between 2018 and 2020 by a worker who later gave the material to Cruelty Free International. The videos were made public in 2021 and triggered public outrage, protests and a judicial investigation.
According to reporting by El País, the Madrid trial was ultimately limited to two specific episodes: one involving a rabbit and another involving blood extraction from rats. The defendants told the court that they acted according to protocol and suggested that the footage did not reflect criminal conduct. The trial has been heard and is awaiting judgment.
The company itself is not on trial. El País has reported that Vivotecnia was left outside the criminal responsibility examined in this proceeding. That legal limit is precisely what has frustrated animal-protection organisations, which argue that the public interest goes beyond individual acts and touches the broader system of oversight inside laboratories.
Europe’s law already recognises animals as sentient beings
The European Union is not starting from a blank page. The European Commission notes that Article 13 of the Treaty on the Functioning of the European Union recognises animals as sentient beings. EU policy also follows the “3Rs” principle: replacing, reducing and refining the use of animals in science.
Directive 2010/63/EU sets the goal of phasing out animal use for research and regulatory purposes as soon as scientifically possible. In practice, however, that phrase has left Europe in a difficult middle ground. Animal testing is officially treated as something to be reduced and eventually replaced, while millions of animals continue to be used each year.
The latest figures underline the gap. European Commission statistics for 2023, reported through the ALURES system, provide the official basis for tracking animal use in science across EU Member States and Norway. Cruelty Free Europe says those figures show around 9.1 million uses of animals in the EU and Norway in 2023, only a small fall from 2022.
The Madrid trial meets a Brussels policy moment
The Vivotecnia case arrives as Brussels is preparing a major policy step: the Roadmap Towards Phasing Out Animal Testing for Chemical Safety Assessments. The Commission says the roadmap is intended to accelerate the move towards replacing, reducing and refining animal testing in chemical safety assessments.
The roadmap was promised in response to the European Citizens’ Initiative “Save Cruelty Free Cosmetics – Commit to a Europe Without Animal Testing”, which gathered more than 1.2 million statements of support. That level of mobilisation shows that animal testing is not only a technical regulatory issue. It is a democratic issue, too.
At the same time, the European Parliament has moved to strengthen the role of non-animal approaches in the future work of the European Chemicals Agency. In late April, MEPs backed Parliament’s position on a new basic regulation for ECHA, with Cruelty Free Europe highlighting that the vote included stronger support for the development, validation and regulatory acceptance of non-animal methods.
The science debate cannot ignore accountability
Supporters of animal research argue that some procedures remain necessary for medicines, safety testing and public health. Vivotecnia’s own institutional statement says animal experimentation has played a role in developing medical treatments and that animal welfare is central to research quality.
That argument cannot simply be dismissed. Europe’s challenge is to protect human health, environmental safety and scientific progress while also respecting the ethical status of animals. But the Vivotecnia case shows why public trust depends on more than scientific necessity. It depends on inspection, transparency, accountability and the credible enforcement of welfare standards.
If painful procedures are truly unavoidable, the public has a right to know that they are strictly controlled. If non-animal methods already exist, the public has a right to ask why animal use continues. And if laboratory abuses occur, the public has a right to expect consequences that reach beyond symbolic punishment.
A test of Europe’s credibility
The EU often presents itself as a global leader in animal welfare and ethical regulation. That leadership now depends on implementation. A roadmap without deadlines will not be enough. A database without enforcement will not be enough. A commitment to alternatives will not be enough unless regulators, research institutions and companies are required to use them whenever they are scientifically valid.
This is also part of a wider European debate on the protection of animals and the environment, an issue followed by The European Times in its coverage of animal protection in Cyprus and other cross-border welfare concerns.
The Madrid court will decide the criminal responsibility of two individuals. Brussels must answer a larger question: whether Europe’s animal-testing system is moving fast enough from harm reduction to real replacement.
The distinction matters. The first is a legal case. The second is a test of European values.
Keywords
animal testing
Vivotecnia
Madrid trial
Cruelty Free Europe
Cruelty Free International
EU animal welfare
non-animal testing methods
ECHA
European Commission roadmap
chemical safety assessment
animal experiments Europe
EU research ethics
